» Authors » Andrea M Collins

Andrea M Collins

Explore the profile of Andrea M Collins including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 49
Citations 4895
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stewart T, Brodrick E, Reed M, Collins A, Daulton E, Adams E, et al.
iScience . 2024 Sep; 27(9):110610. PMID: 39262786
Diagnosis of respiratory tract infections (RTIs), especially in primary care, is typically made on clinical features and in the absence of quick and reliable diagnostic tests. Even in secondary care,...
2.
Carter E, Morton B, ElSafadi D, Jambo K, Kenny-Nyazika T, Hyder-Wright A, et al.
Wellcome Open Res . 2024 Sep; 8:424. PMID: 39219857
Tuberculosis (TB) caused 1.5 million deaths in 2020, making it the leading infectious killer after COVID-19. Bacille Calmette-Guerin (BCG) is the only licensed vaccine against TB but has sub-optimal efficacy...
3.
Mitsi E, Nikolaou E, Goncalves A, Blizard A, Hill H, Farrar M, et al.
Cell Host Microbe . 2024 Aug; 32(9):1608-1620.e4. PMID: 39181126
Epidemiological studies report the impact of co-infection with pneumococcus and respiratory viruses upon disease rates and outcomes, but their effect on pneumococcal carriage acquisition and bacterial load is scarcely described....
4.
Urban B, Goncalves A, Loukov D, Passos F, Reine J, Gonzalez-Dias P, et al.
Mucosal Immunol . 2024 Jul; 17(5):973-989. PMID: 38950826
Streptococcus pneumoniae colonization in the upper respiratory tract is linked to pneumococcal disease development, predominantly affecting young children and older adults. As the global population ages and comorbidities increase, there...
5.
Hazenberg P, Robinson R, Farrar M, Solorzano C, Hyder-Wright A, Liatsikos K, et al.
BMJ Open . 2024 Jan; 14(1):e075948. PMID: 38199622
Introduction: Since the introduction of pneumococcal conjugate vaccines, pneumococcal disease rates have declined for many vaccine-type serotypes. However, serotype 3 (SPN3) continues to cause significant disease and is identified in...
6.
Drysdale S, Cathie K, Flamein F, Knuf M, Collins A, Hill H, et al.
N Engl J Med . 2023 Dec; 389(26):2425-2435. PMID: 38157500
Background: The safety of the monoclonal antibody nirsevimab and the effect of nirsevimab on hospitalizations for respiratory syncytial virus (RSV)-associated lower respiratory tract infection when administered in healthy infants are...
7.
German E, Nabwera H, Robinson R, Shiham F, Liatsikos K, Parry C, et al.
PLoS One . 2023 Nov; 18(11):e0294133. PMID: 37943741
Longitudinal, community-based sampling is important for understanding prevalence and transmission of respiratory pathogens. Using a minimally invasive sampling method, the FAMILY Micro study monitored the oral, nasal and hand microbiota...
8.
Mitsi E, Diniz M, Reine J, Collins A, Robinson R, Hyder-Wright A, et al.
Nat Commun . 2023 Oct; 14(1):6815. PMID: 37884506
Respiratory mucosal immunity induced by vaccination is vital for protection from coronavirus infection in animal models. In humans, the capacity of peripheral vaccination to generate sustained immunity in the lung...
9.
Hill H, Mitsi E, Nikolaou E, Blizard A, Pojar S, Howard A, et al.
Am J Respir Crit Care Med . 2023 Aug; 208(8):868-878. PMID: 37556679
Pneumococcal pneumonia remains a global health problem. Pneumococcal colonization increases local and systemic protective immunity, suggesting that nasal administration of live attenuated (Spn) strains could help prevent infections. We used...
10.
Fyles F, Hill H, Duncan G, Carter E, Solorzano C, Davies K, et al.
BMJ Open Respir Res . 2023 Jun; 10(1). PMID: 37277188
Introduction: Respiratory syncytial virus (RSV) is a common respiratory virus, particularly affecting children, and can cause respiratory infections such as croup and bronchiolitis. The latter is a leading cause of...